Epigenetics · 2020 · 24 citations · 33 references
Life SciencesImmunologyMolecular BiologyCellular ImmunologyEpigeneticsImmunoregulationDna Methylation ProfilingImmune Cell DifferentiationImmune Checkpoint RegulationImmune CheckpointsImmune Gene RegulationMyeloid-derived Suppressor CellsAntigen Presenting CellsImmunosuppressive Myeloid CellsMyeloid Cell CheckpointsMyeloid-derived Suppressor Cell Epigenetic RegulationMyeloid-derived Suppressor Cell ImmunosuppressionMyeloid-derived Suppressor Cell Transcriptional RegulationPromoter MethylationSuppressive Myeloid Cells
Myeloid cells, including antigen-presenting cells (APCs) and myeloid-derived suppressor cells (MDSCs) play opposing roles to orchestrate innate and adaptive immune responses during physiological and pathological conditions. We investigated the role of DNA methylation in regulating the transcription of inhibitory/suppressive molecules in myeloid suppressive cells (identified as CD33+HLA-DR–) in comparison to APCs. We selected a number of immune checkpoints (ICs), IC ligands, and immunosuppressive molecules that have been implicated in MDSC function, including PD-L1, TIM-3, VISTA, galectin-9, TGF-β, ARG1 and MMP9. We examined their mRNA expression levels, and investigated whether DNA methylation regulates their transcription in sorted myeloid cell subpopulations. We found that mRNA levels of PD-L1, TIM-3, TGF-β, ARG1 and MMP9 in CD33+HLA-DR– cells were higher than APCs. However, VISTA and galectin-9 mRNA levels were relatively similar in both myeloid subpopulations. CpG islands in the promoter regions of TGF-β1, TIM-3 and ARG1 were highly unmethylated in CD33+HLA-DR–cells, compared with APCs, suggesting that DNA methylation is one of the key mechanisms, which regulate their expression. However, we did not find differences in the methylation status of PD-L1 and MMP9 between CD33+HLA-DR– and APCs, suggesting that their transcription could be regulated via other genetic and epigenetic mechanisms. The promoter methylation status of VISTA was relatively similar in both myeloid subpopulations. This study provides novel insights into the epigenetic mechanisms, which control the expression of inhibitory/suppressive molecules in circulating CD33+HLA-DR– cells in a steady-state condition, possibly to maintain immune tolerance and haemostasis.
33
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Srinivas Nagaraj, Kapil Gupta, Leo Kinarsky et al. · Nature Medicine · 2007 · 1.1K citations · Full text
Life Sciences, Immunology, Oncology +14